Vaxart, Inc. announced that it has appointed Phillip Lee as its Chief Financial Officer (CFO), effective immediately. Mr. Lee has almost 15 years of strategic finance and advisory experience in the biotechnology industry. During his career, he has helped raise over $1 billion of capital and worked on more than $20 billion of M&A transactions, including partnerships, asset acquisitions, mergers, spin-offs and royalty monetizations.

Most recently, he was CFO and Chief Operating Officer at Clover Biopharmaceuticals and prior to that held finance leadership positions at several biotechnology companies. Mr. Lee began his career as an investment banker and was a principal and founding member of Centerview Partners' healthcare advisory practice. Mr. Lee earned dual bachelor's degrees in Electrical Engineering and Computer Sciences and Business Administration from the University of California, Berkeley.